Public Health Service of Amsterdam
Quick facts
Marketed products
- Fosfomycin Oral Suspension · Infectious Disease
Fosfomycin inhibits bacterial cell wall synthesis by inactivating the enzyme enolpyruvate transferase, preventing peptidoglycan cross-linking.
Phase 3 pipeline
- Gentamicin Sulfate, Injectable · Infectious Disease
Gentamicin sulfate is an aminoglycoside antibiotic that binds to bacterial 30S ribosomal subunits and inhibits protein synthesis, leading to bacterial cell death.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Public Health Service of Amsterdam portfolio CI brief
- Public Health Service of Amsterdam pipeline updates RSS
Frequently asked questions about Public Health Service of Amsterdam
What are Public Health Service of Amsterdam's marketed drugs?
Top marketed products include Fosfomycin Oral Suspension.
What is Public Health Service of Amsterdam's pipeline?
Public Health Service of Amsterdam has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Gentamicin Sulfate, Injectable.
Related
- Fosfomycin Oral Suspension · Infectious Disease
- Sector hub: All tracked pharma companies